Request Sample Inquiry
Liver Cancer Diagnostics Market

Liver Cancer Diagnostics Market

Liver Cancer Diagnostics Market - Global Industry Assessment & Forecast

img
Biotechnology and Life Sciences
Number Of Pages # Pages:

149

Base Year:

2023

Date

Jun - 2024

Format:

PDF XLS PPT

Report Code:

VMR-2527

Segments Covered
  • By Test Type By Test Type Laboratory Tests, Imaging, Endoscopy, Biopsy, Other Test Types
  • By End Use By End Use Hospitals & Diagnostic Laboratories, Academic & Research Institutes, Pharmaceutical & CRO Laboratories
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base YearBase Year: 2023
Forecast YearsForecast Years: 2024 - 2032
Historical YearsHistorical Years: 2018 - 2022
Revenue 2023Revenue 2023: USD 10.17 Billion
Revenue 2032Revenue 2032: USD 19.31 Billion
Revenue CAGRRevenue CAGR (2024 - 2032): 7.38%
Fastest Growing Region Fastest Growing Region (2024 - 2032) Asia Pacific
Largest Region Largest Region (2023): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
  1. Executive Dashboard
    1. Strategic Imperatives
  2. Premium Insights
    1. Top 3 Trends to Watch
    2. Demand and Supply Trends
    3. Top 3 Strategies Followed by Major Players
    4. Top 3 Predictions by Vantage Market Research
    5. Top Investment Pockets
    6. Insights from Primary Respondents
  3. Global Liver Cancer Diagnostics Market - Segment Analysis
    1. Overview
    2. Global Liver Cancer Diagnostics Market, 2016 - 2028 (USD Million)
    3. Global Liver Cancer Diagnostics Market - by Test Type
      1. By Laboratory Tests
      2. By Imaging
      3. By Endoscopy
      4. By Biopsy
      5. By Other Test Types
    4. Global Liver Cancer Diagnostics Market - by End Use
      1. By Hospitals & Diagnostic Laboratories
      2. By Academic & Research Institutes
      3. By Pharmaceutical & CRO Laboratories
    5. Global Liver Cancer Diagnostics Market - by region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    6. Market comparative analysis
  4. North America Liver Cancer Diagnostics Market - Segment Analysis
    1. Overview
    2. North America Liver Cancer Diagnostics Market, 2016 - 2028 (USD Million)
    3. North America Liver Cancer Diagnostics Market, by Test Type
      1. By Laboratory Tests
      2. By Imaging
      3. By Endoscopy
      4. By Biopsy
      5. By Other Test Types
    4. North America Liver Cancer Diagnostics Market, by End Use
      1. By Hospitals & Diagnostic Laboratories
      2. By Academic & Research Institutes
      3. By Pharmaceutical & CRO Laboratories
    5. North America Liver Cancer Diagnostics Market, by Country
      1. U.S.
        1. U.S. Liver Cancer Diagnostics Market, By Test Type
          1. By Laboratory Tests
          2. By Imaging
          3. By Endoscopy
          4. By Biopsy
          5. By Other Test Types
        2. U.S. Liver Cancer Diagnostics Market, By End Use
          1. By Hospitals & Diagnostic Laboratories
          2. By Academic & Research Institutes
          3. By Pharmaceutical & CRO Laboratories
      2. Canada
        1. Canada Liver Cancer Diagnostics Market, By Test Type
          1. By Laboratory Tests
          2. By Imaging
          3. By Endoscopy
          4. By Biopsy
          5. By Other Test Types
        2. Canada Liver Cancer Diagnostics Market, By End Use
          1. By Hospitals & Diagnostic Laboratories
          2. By Academic & Research Institutes
          3. By Pharmaceutical & CRO Laboratories
      3. Mexico
        1. Mexico Liver Cancer Diagnostics Market, By Test Type
          1. By Laboratory Tests
          2. By Imaging
          3. By Endoscopy
          4. By Biopsy
          5. By Other Test Types
        2. Mexico Liver Cancer Diagnostics Market, By End Use
          1. By Hospitals & Diagnostic Laboratories
          2. By Academic & Research Institutes
          3. By Pharmaceutical & CRO Laboratories
  5. Europe Liver Cancer Diagnostics Market - Segment Analysis
    1. Overview
    2. Europe Liver Cancer Diagnostics Market, 2016 - 2028 (USD Million)
    3. Europe Liver Cancer Diagnostics Market, by Test Type
      1. By Laboratory Tests
      2. By Imaging
      3. By Endoscopy
      4. By Biopsy
      5. By Other Test Types
    4. Europe Liver Cancer Diagnostics Market, by End Use
      1. By Hospitals & Diagnostic Laboratories
      2. By Academic & Research Institutes
      3. By Pharmaceutical & CRO Laboratories
    5. Europe Liver Cancer Diagnostics Market, by Country
      1. Germany
        1. Germany Liver Cancer Diagnostics Market, By Test Type
          1. By Laboratory Tests
          2. By Imaging
          3. By Endoscopy
          4. By Biopsy
          5. By Other Test Types
        2. Germany Liver Cancer Diagnostics Market, By End Use
          1. By Hospitals & Diagnostic Laboratories
          2. By Academic & Research Institutes
          3. By Pharmaceutical & CRO Laboratories
      2. UK
        1. UK Market, By Test Type
          1. By Laboratory Tests
          2. By Imaging
          3. By Endoscopy
          4. By Biopsy
          5. By Other Test Types
        2. UK Market, By End Use
          1. By Hospitals & Diagnostic Laboratories
          2. By Academic & Research Institutes
          3. By Pharmaceutical & CRO Laboratories
      3. France
        1. France Liver Cancer Diagnostics Market, By Test Type
          1. By Laboratory Tests
          2. By Imaging
          3. By Endoscopy
          4. By Biopsy
          5. By Other Test Types
        2. France Liver Cancer Diagnostics Market, By End Use
          1. By Hospitals & Diagnostic Laboratories
          2. By Academic & Research Institutes
          3. By Pharmaceutical & CRO Laboratories
      4. Spain
        1. Spain Liver Cancer Diagnostics Market, By Test Type
          1. By Laboratory Tests
          2. By Imaging
          3. By Endoscopy
          4. By Biopsy
          5. By Other Test Types
        2. Spain Liver Cancer Diagnostics Market, By End Use
          1. By Hospitals & Diagnostic Laboratories
          2. By Academic & Research Institutes
          3. By Pharmaceutical & CRO Laboratories
      5. Italy
        1. Italy Liver Cancer Diagnostics Market, By Test Type
          1. By Laboratory Tests
          2. By Imaging
          3. By Endoscopy
          4. By Biopsy
          5. By Other Test Types
        2. Italy Liver Cancer Diagnostics Market, By End Use
          1. By Hospitals & Diagnostic Laboratories
          2. By Academic & Research Institutes
          3. By Pharmaceutical & CRO Laboratories
      6. BENELUX
        1. BENELUX Liver Cancer Diagnostics Market, By Test Type
          1. By Laboratory Tests
          2. By Imaging
          3. By Endoscopy
          4. By Biopsy
          5. By Other Test Types
        2. BENELUX Liver Cancer Diagnostics Market, By End Use
          1. By Hospitals & Diagnostic Laboratories
          2. By Academic & Research Institutes
          3. By Pharmaceutical & CRO Laboratories
      7. Rest of Europe
        1. Rest Of Europe Liver Cancer Diagnostics Market, By Test Type
          1. By Laboratory Tests
          2. By Imaging
          3. By Endoscopy
          4. By Biopsy
          5. By Other Test Types
        2. Rest Of Europe Liver Cancer Diagnostics Market, By End Use
          1. By Hospitals & Diagnostic Laboratories
          2. By Academic & Research Institutes
          3. By Pharmaceutical & CRO Laboratories
  6. Asia Pacific Liver Cancer Diagnostics Market - Segment Analysis
    1. Overview
    2. Asia Pacific Liver Cancer Diagnostics Market, 2016 - 2028 (USD Million)
    3. Asia Pacific Liver Cancer Diagnostics Market, by Test Type
      1. By Laboratory Tests
      2. By Imaging
      3. By Endoscopy
      4. By Biopsy
      5. By Other Test Types
    4. Asia Pacific Liver Cancer Diagnostics Market, by End Use
      1. By Hospitals & Diagnostic Laboratories
      2. By Academic & Research Institutes
      3. By Pharmaceutical & CRO Laboratories
    5. Asia Pacific Liver Cancer Diagnostics Market, by Country
      1. China
        1. China Liver Cancer Diagnostics Market, By Test Type
          1. By Laboratory Tests
          2. By Imaging
          3. By Endoscopy
          4. By Biopsy
          5. By Other Test Types
        2. China Liver Cancer Diagnostics Market, By End Use
          1. By Hospitals & Diagnostic Laboratories
          2. By Academic & Research Institutes
          3. By Pharmaceutical & CRO Laboratories
      2. Japan
        1. Japan Liver Cancer Diagnostics Market, By Test Type
          1. By Laboratory Tests
          2. By Imaging
          3. By Endoscopy
          4. By Biopsy
          5. By Other Test Types
        2. Japan Liver Cancer Diagnostics Market, By End Use
          1. By Hospitals & Diagnostic Laboratories
          2. By Academic & Research Institutes
          3. By Pharmaceutical & CRO Laboratories
      3. India
        1. India Liver Cancer Diagnostics Market, By Test Type
          1. By Laboratory Tests
          2. By Imaging
          3. By Endoscopy
          4. By Biopsy
          5. By Other Test Types
        2. India Liver Cancer Diagnostics Market, By End Use
          1. By Hospitals & Diagnostic Laboratories
          2. By Academic & Research Institutes
          3. By Pharmaceutical & CRO Laboratories
      4. South Korea
        1. South Korea Liver Cancer Diagnostics Market, By Test Type
          1. By Laboratory Tests
          2. By Imaging
          3. By Endoscopy
          4. By Biopsy
          5. By Other Test Types
        2. South Korea Liver Cancer Diagnostics Market, By End Use
          1. By Hospitals & Diagnostic Laboratories
          2. By Academic & Research Institutes
          3. By Pharmaceutical & CRO Laboratories
      5. South East Asia
        1. South East Asia Liver Cancer Diagnostics Market, By Test Type
          1. By Laboratory Tests
          2. By Imaging
          3. By Endoscopy
          4. By Biopsy
          5. By Other Test Types
        2. South East Asia Liver Cancer Diagnostics Market, By End Use
          1. By Hospitals & Diagnostic Laboratories
          2. By Academic & Research Institutes
          3. By Pharmaceutical & CRO Laboratories
      6. Rest of Asia Pacific
        1. Rest of Asia Pacific Liver Cancer Diagnostics Market, By Test Type
          1. By Laboratory Tests
          2. By Imaging
          3. By Endoscopy
          4. By Biopsy
          5. By Other Test Types
        2. Rest of Asia Pacific Liver Cancer Diagnostics Market, By End Use
          1. By Hospitals & Diagnostic Laboratories
          2. By Academic & Research Institutes
          3. By Pharmaceutical & CRO Laboratories
  7. Latin America Liver Cancer Diagnostics Market - Segment Analysis
    1. Overview
    2. Latin America Liver Cancer Diagnostics Market, 2016 - 2028 (USD Million)
    3. Latin America Liver Cancer Diagnostics Market, by Test Type
      1. By Laboratory Tests
      2. By Imaging
      3. By Endoscopy
      4. By Biopsy
      5. By Other Test Types
    4. Latin America Liver Cancer Diagnostics Market, by End Use
      1. By Hospitals & Diagnostic Laboratories
      2. By Academic & Research Institutes
      3. By Pharmaceutical & CRO Laboratories
    5. Latin America Liver Cancer Diagnostics Market, by Country
      1. Brazil
        1. Brazil Liver Cancer Diagnostics Market, By Test Type
          1. By Laboratory Tests
          2. By Imaging
          3. By Endoscopy
          4. By Biopsy
          5. By Other Test Types
        2. Brazil Liver Cancer Diagnostics Market, By End Use
          1. By Hospitals & Diagnostic Laboratories
          2. By Academic & Research Institutes
          3. By Pharmaceutical & CRO Laboratories
      2. Argentina
        1. Argentina Liver Cancer Diagnostics Market, By Test Type
          1. By Laboratory Tests
          2. By Imaging
          3. By Endoscopy
          4. By Biopsy
          5. By Other Test Types
        2. Argentina Liver Cancer Diagnostics Market, By End Use
          1. By Hospitals & Diagnostic Laboratories
          2. By Academic & Research Institutes
          3. By Pharmaceutical & CRO Laboratories
      3. Rest of Latin America
        1. Rest of Latin America Liver Cancer Diagnostics Market, By Test Type
          1. By Laboratory Tests
          2. By Imaging
          3. By Endoscopy
          4. By Biopsy
          5. By Other Test Types
        2. Rest of Latin America Liver Cancer Diagnostics Market, By End Use
          1. By Hospitals & Diagnostic Laboratories
          2. By Academic & Research Institutes
          3. By Pharmaceutical & CRO Laboratories
  8. Middle East & Africa Liver Cancer Diagnostics Market - Segment Analysis
    1. Overview
    2. Middle East & Africa Liver Cancer Diagnostics Market, 2016 - 2028 (USD Million)
    3. Middle East & Africa Liver Cancer Diagnostics Market, by Test Type
      1. By Laboratory Tests
      2. By Imaging
      3. By Endoscopy
      4. By Biopsy
      5. By Other Test Types
    4. Middle East & Africa Liver Cancer Diagnostics Market, by End Use
      1. By Hospitals & Diagnostic Laboratories
      2. By Academic & Research Institutes
      3. By Pharmaceutical & CRO Laboratories
    5. Middle East & Africa Liver Cancer Diagnostics Market, by Country
      1. GCC Countries
        1. GCC Countries Liver Cancer Diagnostics Market, By Test Type
          1. By Laboratory Tests
          2. By Imaging
          3. By Endoscopy
          4. By Biopsy
          5. By Other Test Types
        2. GCC Countries Liver Cancer Diagnostics Market, By End Use
          1. By Hospitals & Diagnostic Laboratories
          2. By Academic & Research Institutes
          3. By Pharmaceutical & CRO Laboratories
      2. South Africa
        1. South Africa Liver Cancer Diagnostics Market, By Test Type
          1. By Laboratory Tests
          2. By Imaging
          3. By Endoscopy
          4. By Biopsy
          5. By Other Test Types
        2. South Africa Liver Cancer Diagnostics Market, By End Use
          1. By Hospitals & Diagnostic Laboratories
          2. By Academic & Research Institutes
          3. By Pharmaceutical & CRO Laboratories
      3. Rest of Middle East & Africa
        1. Rest of Middle East & Africa Liver Cancer Diagnostics Market, By Test Type
          1. By Laboratory Tests
          2. By Imaging
          3. By Endoscopy
          4. By Biopsy
          5. By Other Test Types
        2. Rest of Middle East & Africa Liver Cancer Diagnostics Market, By End Use
          1. By Hospitals & Diagnostic Laboratories
          2. By Academic & Research Institutes
          3. By Pharmaceutical & CRO Laboratories
  9. Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter's Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
  10. COVID 19 Impact Analysis
    1. Key strategies undertaken by companies to tackle COVID-19
    2. Short term dynamics
    3. Long term dynamics
  11. Marketing Stratagy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
  12. Competative Landscape
    1. Competition Matrix - 2021
    2. Company Market Share Analysis - 2021
    3. Key Company Activities, 2018 - 2021
    4. Strategic Developments - Heat Map Analysis
    5. Company Offering Evaluation
    6. Company Regional Presence Evaluation
  13. Company Profiles
    1. Abbott Laboratories (U.S.)
    2. Thermo Fisher Scientific Inc. (U.S.)
    3. F. Hoffmann-La Roche Ltd. (Switzerland)
    4. Qiagen N.V. (Germany)
    5. Siemens Healthineers (Germany)
    6. Becton Dickinson & Company (U.S.)
    7. Illumina Inc. (U.S.)
    8. Epigenomics AG (Germany)
    9. Koninklijke Philips N.V. (Netherlands)
    10. Fujifilm Medical Systems U.S.A. Inc. (U.S.)
  14. Key Primary Respondents - VERBATIM
  15. Discussion Guide
  16. Customization Offered
  17. Annexure
  18. List of Figures
  19. List of Tables
  20. List of Abbreviations
Vantage Market Research | 03-Jul-2024
Revolutionizing Liver Cancer Care: AI-Powered Predictive Models and Innovative Therapies Herald New Era in Diagnostics
FAQ
Frequently Asked Question

  • The global Liver Cancer Diagnostics valued at USD 10.17 Billion in 2023 and is expected to reach USD 19.31 Billion in 2032 growing at a CAGR of 7.38%.

  • The prominent players in the market are Abbott Laboratories (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Qiagen N.V. (Germany), Siemens Healthineers (Germany), Becton Dickinson & Company (U.S.), Illumina Inc. (U.S.), Epigenomics AG (Germany), Koninklijke Philips N.V. (Netherlands), Fujifilm Medical Systems U.S.A. Inc. (U.S.).

  • The market is project to grow at a CAGR of 7.38% between 2024 and 2032.

  • The driving factors of the Liver Cancer Diagnostics include

  • North America was the leading regional segment of the Liver Cancer Diagnostics in 2023.

Related Reports
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies Privacy Policy